Dr. Elizabeth E. Uhlenhake, MD

Dr. Uhlenhake practices at The Dermatology Group, Inc in Mason, Ohio.

Dr. Uhlenhake's NPI, 1215168745, was assigned on July 31, 2009. Dr. Uhlenhake holds Ohio license 35-122560.

Dr. Uhlenhake's primary practice is The Dermatology Group, Inc, at 5298 Socialville Foster Rd, Mason, OH 45040 in Warren County. The practice phone is (513) 770-4212.

Dr. Uhlenhake's primary practice is The Dermatology Group, Inc in Mason, Ohio. The medical group on file is DOCS Dermatology (The Dermatology Group). Dmand AI also links Dr. Uhlenhake to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uhlenhake practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Uhlenhake's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Uhlenhake's licenses on file in 2 states: Ohio and Colorado.

CMS data shows 19,344 Medicare services from Dr. Uhlenhake across 20 procedure codes in 2024, for 8,480 Medicare patients. Medicare paid $1,098,081 for them. Every service was in an office.

CMS counts 8,480 Medicare patients who saw Dr. Uhlenhake in 2024. The largest group is 65 to 74, with 3,950 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Uhlenhake's median patient age at 68, with 52% women.

In 2024, Dr. Uhlenhake wrote 181 Medicare Part D claims for 69 patients. 90% of them were for generic drugs. CMS names the drug for 139 of them, across 8 drugs with 11 or more claims each, at $67,854 in total drug cost. In 2023, CMS named 126 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Uhlenhake for performance year 2024, reported as part of a group. Dr. Uhlenhake accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of melanoma (skin cancer) excision by Dr. Uhlenhake, more than 78% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Uhlenhake, published from 2011 to 2022. 2016 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Immunohistochemistry. Dr. Uhlenhake has published most often in J Cutan Pathol. Dr. Uhlenhake's most frequent co-authors are Tatyana Milman, MD and Alice C. Watson, MD.

CMS Open Payments shows 93 general payments to Dr. Uhlenhake from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Athenex Pharmaceutical Division, LLC paid the most, $3,561.